1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews
(
- Contribution to journal › Article
-
Mark
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis : The UPSIDE study protocol
(
- Contribution to journal › Article
- 2020
-
Mark
Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosis
(
- Contribution to journal › Article
-
Mark
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis : The European Scleroderma Observational Study
(
- Contribution to journal › Article
-
Mark
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
(
- Contribution to journal › Article
- 2017
-
Mark
The arachidonate 5-lipoxygenase activating protein gene polymorphism is associated with the risk of scleroderma-related interstitial lung disease : A multicentre European Scleroderma Trials and Research group (EUSTAR) study
(
- Contribution to journal › Article
-
Mark
Treatment outcome in early diffuse cutaneous systemic sclerosis : The European Scleroderma Observational Study (ESOS)
(
- Contribution to journal › Article
- 2016
-
Mark
Brief Report : IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
(
- Contribution to journal › Article
- 2013
-
Mark
Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study
(
- Contribution to journal › Article